Literature DB >> 22441968

Multiclinical experiences in erythema nodosum: rheumatology clinics versus dermatology and infection diseases clinics.

Bunyamin Kisacik1, Ahmet Mesut Onat, Yavuz Pehlivan.   

Abstract

Erythema nodosum (EN) is the most common cause of inflammatory nodules and usually affects the lower extremities and especially pretibial regions. EN may be idiopathic or associated with a wide spectrum of conditions including systemic diseases, infection, treatment with various drugs, pregnancy, and exceptionally with malignancies. The purpose of this study is to investigate the EN patients with different etiologies and laboratory features admitted to the rheumatology department and to compare them with other EN patients admitted to different departments including dermatology and infectious diseases. Totally, 107 patients diagnosed with EN (male/female: 37/70) were enrolled in the study. Of the 107 EN patients, 37 participants who were categorized as primary (idiopathic) EN (34.6 %) had not any underlying diseases or precipitating events. Majority of the participants were women (male/female: 12/25; mean age: 42.9 ± 9.2 years). Precisely, 70 EN (secondary EN) patients (65.4 %) had an underlying disease (male/female: 25/45; mean age: 36.1 ± 10.1). Behçet's disease (BD) was the foremost (n = 40, 37.4 %), followed by sarcoidosis (n = 17, 15.9 %), post-streptococcal (n = 9, 8.4 %), and other rheumatologic disease (one patient temporal arthritis, one patient Sjögren's syndrome, 1.9 %). Consequently, it is observed that BD, sarcoidosis, and post-streptococcal infection were found as the main etiologies of EN patients treated in our rheumatology department. These diseases should be kept in mind as an etiological factor in the management of EN.

Entities:  

Mesh:

Year:  2012        PMID: 22441968     DOI: 10.1007/s00296-012-2413-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  Recurrent erythema nodosum leprosum precipitated by antileprosy drugs.

Authors:  P Bhargava; C M Kuldeep; N K Mathur
Journal:  Int J Lepr Other Mycobact Dis       Date:  1996-12

4.  Henoch-Schönlein purpura-like disease representing a flare of Behçet's disease.

Authors:  G Golan; R Beeri; D Mevorach
Journal:  Br J Rheumatol       Date:  1994-12

5.  Erythema nodosum.

Authors:  O F Jillson
Journal:  Cutis       Date:  1982-02

6.  Erythema nodosum.

Authors:  J W White
Journal:  Dermatol Clin       Date:  1985-01       Impact factor: 3.478

7.  Erythema nodosum in children: a prospective study.

Authors:  T Kakourou; P Drosatou; F Psychou; K Aroni; P Nicolaidou
Journal:  J Am Acad Dermatol       Date:  2001-01       Impact factor: 11.527

8.  Erythema nodosum associated with diffuse, large B-cell non-Hodgkin lymphoma detected by FDG PET.

Authors:  Kerry A Cheong; Nicholas G Rodgers; Ian D Kirkwood
Journal:  Clin Nucl Med       Date:  2003-08       Impact factor: 7.794

9.  Erythema nodosum and associated diseases. A study of 129 cases.

Authors:  B Cribier; A Caille; E Heid; E Grosshans
Journal:  Int J Dermatol       Date:  1998-09       Impact factor: 2.736

10.  Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies.

Authors:  E L Alexander; T T Provost
Journal:  J Invest Dermatol       Date:  1983-05       Impact factor: 8.551

View more
  2 in total

1.  Examination of the Microbial Spectrum in the Etiology of Erythema Nodosum: A Retrospective Descriptive Study.

Authors:  Ozlem Ozbagcivan; Sevgi Akarsu; Ceylan Avci; Burcu Bahar Inci; Emel Fetil
Journal:  J Immunol Res       Date:  2017-05-28       Impact factor: 4.818

2.  Brucella as an unexpected cause of erythema nodosum.

Authors:  Mete Pekdiker; Sertaç Ketenci
Journal:  Turk J Phys Med Rehabil       Date:  2022-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.